Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

Prime Medicine has surged over 130% in three months, driven by pipeline progress and visibility from recent scientific ...

CRISPR Therapeutics CRSP, along with privately held biotech, Sirius Therapeutics, announced the dosing of the first patient ...

The global mice model market is set to witness a growth rate of ~9% in the next 5 years. Increasing demand for personalized ...

Editas Medicine Inc. (NASDAQ:EDIT) is one of the best performing penny stocks to buy now. On September 5, HC Wainwright ...

Lithuania is rapidly growing as a leading force in the European life sciences scene, with over 400 life sciences companies in ...

Earlier this week, Intellia Therapeutics released new long-term Phase 1 data showing that a single dose of investigational nexiguran ziclumeran (nex-z) delivered deep and sustained serum TTR reduction ...

Market Research Report Highlights Key Trends, Drivers, and InnovationsThe DNA sequencing market has emerged as a cornerstone ...

Basic research, often termed fundamental, frontier, blue-sky, curiosity-driven—or even useless—is the pursuit of knowledge ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.